Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Blinded, Parallel Controlled Phase 3 Clinical Trial to Evaluate the Immunogenicity and Safety of Freeze-dried Human Rabies Vaccine (Without Serum Vero Cells) Administered to People Aged 10-60 Years With Different Immunization Procedures

NCT05969626 is registered in ClinicalTrials.gov with Ningbo Rongan Biological Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT05969626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05969626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Blinded, Parallel Controlled Phase 3 Clinical Trial to Evaluate the Immunogenicity and Safety of Freeze-dried Human Rabies Vaccine (Without Serum Vero Cells) Administered to People Aged 10-60 Years With Different Immunization Procedures
Lead sponsor
Ningbo Rongan Biological Pharmaceutical Co., Ltd.
Phase
Phase 3
Overall status
Unknown status
Start date
August 31, 2023
Completion date
December 31, 2024
Enrollment
2,460 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

rabies